R Baxter

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 28:7267-72. 2010
  2. ncbi Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Pediatr Infect Dis J 30:e41-8. 2011
  3. ncbi Long-term Effectiveness of Varicella Vaccine: A 14-Year, Prospective Cohort Study
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16b, floor, Oakland, CA 94612
    Pediatrics 131:e1389-96. 2013
  4. ncbi Safety of Zostavax™--a cohort study in a managed care organization
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Vaccine 30:6636-41. 2012
  5. ncbi A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 30:2989-98. 2012
  6. ncbi Recurrent Guillain-Barre syndrome following vaccination
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, California 94612, USA
    Clin Infect Dis 54:800-4. 2012
  7. ncbi Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, USA
    BMC Infect Dis 9:37. 2009
  8. ncbi Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Research Institute, Seattle WA, USA
    BMC Infect Dis 9:165. 2009
  9. ncbi A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Pediatr Infect Dis J 29:924-30. 2010
  10. ncbi Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age
    R Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 29:2272-8. 2011

Collaborators

Detail Information

Publications23

  1. ncbi Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 28:7267-72. 2010
    ..To estimate influenza vaccine effectiveness (VE) in preventing hospitalizations in persons over 50 years of age...
  2. ncbi Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Pediatr Infect Dis J 30:e41-8. 2011
    ..An investigational quadrivalent Neisseria meningitidis serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT) has been developed to expand available options for vaccination against invasive meningococcal disease...
  3. ncbi Long-term Effectiveness of Varicella Vaccine: A 14-Year, Prospective Cohort Study
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16b, floor, Oakland, CA 94612
    Pediatrics 131:e1389-96. 2013
    ..A second dose was recommended in the United States in June 2006. Varicella incidence and vaccine effectiveness were assessed in a 14-year prospective study conducted at Kaiser Permanente Northern California...
  4. ncbi Safety of Zostavax™--a cohort study in a managed care organization
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Vaccine 30:6636-41. 2012
    ....
  5. ncbi A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 30:2989-98. 2012
    ..Live attenuated influenza vaccine (LAIV) was licensed in 2003 in the United States for use in individuals aged 5-49 years...
  6. ncbi Recurrent Guillain-Barre syndrome following vaccination
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, California 94612, USA
    Clin Infect Dis 54:800-4. 2012
    ....
  7. ncbi Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, USA
    BMC Infect Dis 9:37. 2009
    ..To assess contemporary patterns of pneumococcal vaccination and revaccination of adults, we conducted a cross-sectional study of adults enrolled in medical care organizations (MCOs) participating in the Vaccine Safety Datalink project...
  8. ncbi Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Research Institute, Seattle WA, USA
    BMC Infect Dis 9:165. 2009
    ..Local reactions are the most commonly reported adverse events following tetanus and diphtheria toxoid (Td) vaccine and the risk of local reactions may increase with number of prior Td vaccinations...
  9. ncbi A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA, USA
    Pediatr Infect Dis J 29:924-30. 2010
    ..This study (NCT00383123) compared the immunogenicity and safety of 2 trivalent inactivated influenza vaccines: Fluarix [GlaxoSmithKline (study vaccine)] and Fluzone [Sanofi Pasteur (control vaccine)] in children 6 months to <18 years...
  10. ncbi Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age
    R Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 29:2272-8. 2011
    ..Alternative methods for influenza vaccine production are needed to ensure adequate supplies...
  11. ncbi Surveillance lessons from first-wave pandemic (H1N1) 2009, Northern California, USA
    Roger Baxter
    Kaiser Permanente Vaccine Study Center, Oakland, California 94612, USA
    Emerg Infect Dis 16:504-6. 2010
    ..A combination of testing and utilization data showed a pattern of disease activity, but this pattern may have been affected by public perception of the epidemic...
  12. ncbi Evidence of bias in studies of influenza vaccine effectiveness in elderly patients
    Roger Baxter
    Vaccine Study Center, Kaiser Permanente, Oakland, California 94612, USA
    J Infect Dis 201:186-9. 2010
    ..We conclude that bias is inherent in studies of influenza vaccination and death among elderly patients...
  13. ncbi Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients
    Roger Baxter
    Permanente Medical Group, Oakland, California 94612, USA
    Infect Control Hosp Epidemiol 29:44-50. 2008
    ..To determine which antibiotics increase or decrease the risk of Clostridium difficile-associated diarrhea (CDAD)...
  14. ncbi Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
    Nicola P Klein
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Vaccine 28:1062-8. 2010
    ..These background incidence rates should prove useful for future observational vaccine safety studies and will help guide evaluation of potential vaccine AID events following introduction of new vaccines...
  15. ncbi Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
    Steven Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 23:485-9. 2004
    ..Secondary objectives included determination of the risk of pneumococcal infections in unvaccinated older children and adults in the same population and the impact of vaccine introduction on patterns of antimicrobial resistance...
  16. ncbi Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa
    G Thomas Ray
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, California, USA
    Clin Infect Dis 41:441-9. 2005
    ..aeruginosa isolates from hospital-acquired infections (hereafter, "hospital-acquired isolates") would be nonsusceptible to ciprofloxacin...
  17. ncbi Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
    Steven Black
    Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, USA
    Vaccine 24:S2-79-80. 2006
    ..There was no evidence of any concomittant increase in pneumococcal disease caused by non-vaccine serotypes. High-level resistance of pneumococci to penicillin fell from a peak of 15% in year 2000 to 5% in the first half of 2003...
  18. ncbi Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
    Nicola P Klein
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatrics 126:e1-8. 2010
    ..Now with data on twice as many vaccine recipients, our goal was to reexamine seizure risk after MMRV vaccine...
  19. ncbi Influenza vaccination and mortality: differentiating vaccine effects from bias
    Bruce Fireman
    Kaiser Permanente, 2000 Broadway, Oakland, CA 94612, USA
    Am J Epidemiol 170:650-6. 2009
    ....
  20. ncbi Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study
    H F Tseng
    Kaiser Permanente, Southern California, Pasadena, CA 91101, USA
    J Intern Med 271:510-20. 2012
    ..The aim of this study was to examine a large cohort of adults who received the zoster vaccine for evidence of an increased risk of prespecified adverse events requiring medical attention...
  21. ncbi An algorithm for treatment of patients with hypersensitivity reactions after vaccines
    Robert A Wood
    Johns Hopkins Hospital, CMSC 1102, 600 N Wolfe St, Baltimore, MD 21287, USA
    Pediatrics 122:e771-7. 2008
    ..We then include 3 cases of suspected allergic reactions to vaccines that have been referred to the Clinical Immunization Safety Assessment network to demonstrate the practical application of the algorithm...
  22. ncbi An observational cohort study of Chlamydia trachomatis treatment in pregnancy
    Lisa Rahangdale
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94110, USA
    Sex Transm Dis 33:106-10. 2006
    ..We evaluated the use, efficacy, and safety of azithromycin compared with erythromycin and amoxicillin in the treatment of genital chlamydial infection during pregnancy...
  23. ncbi Infective endocarditis
    Roger Baxter
    N Engl J Med 346:782-3. 2002